We'd like your feedback
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Contact the study team using the details below to take part. If there are no contact details below please ask your doctor in the first instance.
Dr
Austen
El-Osta
a.el-osta@imperial.ac.uk
Dr
Austen
El-Osta
a.el-osta@imperial.ac.uk
Aos
Alaa
aos.alaa18@imperial.ac.uk
Eva
Riboli Sasco
e.riboli-sasco@imperial.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
Hypertensive diseases
This information is provided directly by researchers, and we recognise that it isn't always easy to understand. We are working with researchers to improve the accessibility of this information. In some summaries, you may come across links to external websites. These websites will have more information to help you better understand the study.
Noncommunicable diseases (NCDs) kill 41 million people each year across the world, with cardiovascular diseases accounting for most NCD deaths. High blood pressure is one of the most readily preventable causes of stroke and other cardiovascular complications and home blood pressure monitoring has been shown to improve blood pressure control among users in comparison standard blood pressure monitoring in the healthcare system. However, several barriers to widespread implementation have been identified, including a lack of adequate training of patients and health care providers as well as the necessity to accommodate the needs of specific demographic groups such as the elderly, people with certain disabilities or lacking access to online technologies. Socio-economic inequalities also pose significant challenges to equal access, use and adoption of eHealth practices, including blood pressure self-monitoring.
As self-monitoring of blood pressure is becoming more routine, it is crucial to investigate current barriers & enablers for the efficient implementation of self-monitoring of blood pressure in the home and community setting in the UK. This is the primary aim of this mixed-methods research study, involving NHS patients and healthcare professionals. This study will be based on a semi-quantitative electronic survey component and a qualitative interviews component. We will first disseminate two eSurveys: one aimed at patients who self-monitor their BP at home using a BP monitor and one aimed at HCPs involved in supporting patients in self-monitoring their BP at home. This survey data will then be completed and further contextualised through the thematic analysis of individual interviews and focus groups carried with patients and HCPs.
This study is funded by NIHR ARC Northwest London. The findings of this research are expected to be scalable and generalisable- thus largely applicable to the United Kingdom and self-monitoring of blood pressure initiatives (e.g. BP@Home). The results of the study will be disseminated in peer-reviewed journals.
Start dates may differ between countries and research sites. The research team are responsible for keeping the information up-to-date.
The recruitment start and end dates are as follows:
Observational type: Cross-sectional;
You can take part if:
You may not be able to take part if:
For patients: • Under 18-year of age • Non-English speaking • Have not used a blood pressure monitor for self-monitoring of their BP within the last 3 years • Patients with limited cognitive capacity • Developmental disorders including autism. • Diagnosis of dementia. • Diagnosis of serious mental illnesses (e.g., schizophrenia, psychosis, severe bipolar disorder, severe major depression) • Patients in end-of-life care or receiving palliate care. • Not willing to provide consent. • Individuals who do not have access to a smartphone, tablet, or pc with internet connectivity. For healthcare professionals: • HCPs who are not involved in supporting patients in self-monitoring their blood pressure • HCPs not willing to provide consent to participate
Below are the locations for where you can take part in the trial. Please note that not all sites may be open.
Dr
Austen
El-Osta
a.el-osta@imperial.ac.uk
Eva
Riboli Sasco
e.riboli-sasco@imperial.ac.uk
Dr
Austen
El-Osta
a.el-osta@imperial.ac.uk
Aos
Alaa
aos.alaa18@imperial.ac.uk
More information about this study, what is involved and how to take part can be found on the study website.
The study is sponsored by Imperial College of Science, Technology and Medicine and funded by NIHR Applied Research Collaboration Northwest London .
Your feedback is important to us. It will help us improve the quality of the study information on this site. Please answer both questions.
Read full details
for Trial ID: CPMS 60960
You can print or share the study information with your GP/healthcare provider or contact the research team directly.
